Final Sempresto Investor Webinar
Sempresto’s Wefunder round is closing soon. Before it does, CEO and Co-Founder Liz Reczek, CFO Matt Copeland and COO Scott Hollander are going live one final time to answer your questions directly.
Liz is a three-time biotech CEO with an MIT PhD who has raised more than $20M in early-stage capital. Matt has taken companies through three IPOs and filed twelve S-1s with the SEC. Scott brings 25+ years commercializing medical devices and pharmaceuticals, and he’s a volunteer EMT who sees anaphylaxis emergencies firsthand.
We’ll cover:
How Sempresto closes the gap left by an autoinjector that hasn’t changed since 1987
Our FDA progress, on track for filing within 18 months, no clinical trials required
Our path to revenue: device sales, annual refills and a telehealth subscription
What’s ahead on the road to our 2028 launch
We’ll close with a live Q&A, your last chance to ask us directly before the round closes.
Review our offering and invest at https://wefunder.com/sempresto.